
Custom crystal commemorating the submission of a New Drug Application (NDA) to the FDA. The application for Impel NeuroPharma’s migraine treatment INP104 was supported by a Phase 3, open-label safety and tolerability trial. (20ALJ356)
Custom crystal commemorating the submission of a New Drug Application (NDA) to the FDA. The application for Impel NeuroPharma’s migraine treatment INP104 was supported by a Phase 3, open-label safety and tolerability trial. (20ALJ356)
"*" indicates required fields
Lucite Embedments: What Works and What Doesn't? Lucite embedments can have extraordinary appeal and perceived value among recipients. The piece shown above is a great example. It's not hard to imagine how a commemorative recognizing the...
Looking for team award ideas? Consider something beyond the usual canned, all-purpose "recognition awards". You've heard the truism: Employee recognition should play an essential role in the culture of your organization. And if you need...
"Custom crystal awards" is a phrase that gets searched pretty frequently online. And you'll get plenty of results if you try it yourself. But many of the results you'll get are missing some crucial information. In some cases, they're just...